"Glad to hear positive report of CEPI’s due diligence to Biofarma and looking forward to good collaboration with CEPI," said Indonesia's top diplomat on her official twitter page on Wednesday.
During the meeting, the Indonesian delegation expressed the country's interest to contribute as CEPI Investor Council, showcasing Indonesia's support to multilateralism.
CEPI, Gavi and the World Health Organization (WHO) have launched COVAX to ensure equitable access to covid-19 vaccines and end the acute phase of the pandemic by the end of 2021.
COVAX is the only solution that will deliver fair, equitable access to vaccines for every country that participates. It aims to produce 2 billion doses of vaccine and distribute them globally and fairly in 2021.
Through COVAX, the risks and benefits of developing and producing vaccines are shared across countries. COVAX works by pooling financial resources to develop vaccines, purchase them at scale, and investing up-front in manufacturing so that vaccines are ready to be distributed as soon as they are licensed.